1. Home
  2. Analysis
  3. Lipitor
  4. Lupkynis

Lipitor and Lupkynis drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lipitor (atorvastatin calcium) and Lupkynis (voclosporin). Common drug interactions include headache among females and blood creatinine increased among males.

The phase IV clinical study analyzes what interactions people have when they take Lipitor and Lupkynis. It is created by eHealthMe based on reports of 14 people who take the same drugs from the FDA, and is updated regularly.

What is Lipitor?

Lipitor has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 259,047 Lipitor users. Check the latest studies of Lipitor.

What is Lupkynis?

Lupkynis has active ingredients of voclosporin. eHealthMe is studying from 4,517 Lupkynis users. Check the latest studies of Lupkynis.

On Jul, 12, 2026

14 people who take Lipitor and Lupkynis together, and have interactions are studied.

Lipitor and Lupkynis drug interactions.

What are the common drug interactions of Lipitor and Lupkynis, by gender? *:

female:

  1. Headache (pain in head)
  2. Heart rate increased
  3. Hypotension (abnormally low blood pressure)
  4. Rash pruritic (redness with itching)
  5. Vertigo
  6. Visual impairment
  7. Dyspepsia (indigestion)
  8. Blood albumin decreased
  9. Blood creatine increased
  10. Complement factor c3 decreased

male:

  1. Blood creatinine increased

What are the common drug interactions of Lipitor and Lupkynis, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Blood creatinine increased
  2. Anxiety
  3. Dizziness
  4. Drug intolerance (drug sensitivity)
  5. Headache (pain in head)
  6. Heart rate increased
  7. Hypotension (abnormally low blood pressure)
  8. Vertigo
  9. Visual impairment
  10. Joint swelling

50-59:

  1. Pain in extremity
  2. Peripheral swelling
  3. Proteinuria (presence of protein in the urine)
  4. Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue)
  5. Abdominal pain upper
  6. Asthenia (weakness)
  7. Chest pain
  8. Dry skin
  9. Nausea (feeling of having an urge to vomit)
  10. Pruritus (severe itching of the skin)

60+:

  1. Abdominal pain upper
  2. Rash pruritic (redness with itching)
  3. Dyspepsia (indigestion)

What are the existing conditions these people have? *

  1. Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 14 people, 100.00%
  2. Nausea (feeling of having an urge to vomit): 2 people, 14.29%
  3. Hypersensitivity: 2 people, 14.29%
  4. High Blood Pressure: 2 people, 14.29%
  5. Visual Impairment: 1 person, 7.14%
  6. Stress And Anxiety: 1 person, 7.14%
  7. Rashes (redness): 1 person, 7.14%
  8. Pain: 1 person, 7.14%
  9. Nausea And Vomiting: 1 person, 7.14%
  10. Muscle Spasms (muscle contraction): 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Lipitor and Lupkynis?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lipitor and Lupkynis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lipitor:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Lupkynis:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lipitor and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lupkynis and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium and voclosporin (the active ingredients of Lipitor and Lupkynis, respectively), and Lipitor and Lupkynis (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2026 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.